A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
- Conditions
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 192
- Registration Number
- NCT06611163
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
- Conditions
- Interventions
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 10
- Registration Number
- NCT06425900
- Locations
- 🇺🇸
Dermatology Consulting Services, PLLC, High Point, North Carolina, United States
A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 10
- Registration Number
- NCT06415305
- Locations
- 🇺🇸
Skin Sciences, PLLC, Louisville, Kentucky, United States
A Study to Evaluate the Impact of Clacoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 50
- Registration Number
- NCT06415292
- Locations
- 🇺🇸
Dermatology Consulting Services, PLLC, High Point, North Carolina, United States
A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 40
- Registration Number
- NCT06415279
- Locations
- 🇺🇸
Dermatology Consulting Services, PLLC, High Point, North Carolina, United States
A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 10
- Registration Number
- NCT06336629
- Locations
- 🇺🇸
Skin Sciences, PLLC, Louisville, Kentucky, United States
A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
- Conditions
- Interventions
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 20
- Registration Number
- NCT06336603
- Locations
- 🇺🇸
Skin Sciences, PLLC, Louisville, Kentucky, United States
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
- Conditions
- Interventions
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 599
- Registration Number
- NCT05022004
- Locations
- 🇮🇳
Dr. BR Ambedkar Medical College and hospital, Bangalore, Karnataka, India
🇮🇳Rising Retina Clinic, Ahmedabad, Gujarat, India
🇮🇳Dr Agarwal's Eye Hospital, Tirunelveli, Tamil Nadu, India
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 650
- Registration Number
- NCT04991116
- Locations
- 🇨🇦
Sunpharma site no 95, Trois-Rivières, Canada
🇮🇳Sunpharma site no 92, Surat, Gujrat, India
🇮🇳Sunpharma site no 91, Hubli, Karnataka, India
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 238
- Registration Number
- NCT04684485
- Locations
- 🇺🇸
Site # 09, Hialeah, Florida, United States
🇺🇸Site # 03, Dallas, Texas, United States
🇺🇸Site # 08, West Lafayette, Indiana, United States